Cancer Genetics Inc.

NASDAQ:CGIX  
2.54
+0.08 (+3.25%)
Earnings Announcements

Cancer Genetics Reports Q3 2020 Financial Results

Published: 11/12/2020 22:00 GMT
Cancer Genetics Inc (CGIX) - Cancer Genetics Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.58 From Continuing Operations.
Q3 Revenue Fell 24 Percent to $1.6 Million.